Aclaris Therapeutics (ACRS) Tops Q2 EPS by 3c, misses on revenue

Go back to Aclaris Therapeutics (ACRS) Tops Q2 EPS by 3c, misses on revenue
(NASDAQ: ACRS) Delayed: 5.72 -0.14 (2.39%)
Previous Close $5.86    52 Week High $33.88 
Open $5.82    52 Week Low $14.12 
Day High $5.86    P/E N/A 
Day Low $5.64    EPS $0.00 
Volume 207,567